Townsend John Insider Trades

Insider Trading History

Track insider trading activity for Townsend John. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Unicycive Therapeutics
Unicycive Therapeutics UNCY
CFO
Holding Value $1.22M 169,500 shares
Last Trade
May 14, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.45M 169,500 shares
$8.56
$7.20
Unicycive Therapeutics
Unicycive Therapeutics UNCY
Chief Financial Officer
Holding Value $731k 101,557 shares
Last Trade
Jul 28, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$47.1k 10,000 shares
$4.71
$7.20
Unicycive Therapeutics
Unicycive Therapeutics UNCY
Chief Financial Officer
Holding Value $6.59M 915,565 shares
Last Trade
Aug 12, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$138k 40,256 shares
$3.44
$7.20
Unicycive Therapeutics
Unicycive Therapeutics UNCY
Chief Financial Officer
Holding Value $6.3M 875,309 shares
Last Trade
Apr 15, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.6M 228,119 shares
$11.40
$7.20
Unicycive Therapeutics
Unicycive Therapeutics UNCY
Chief Financial Officer
Holding Value $4.66M 647,190 shares
Last Trade
Aug 28, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.28M 570,329 shares
$7.50
$7.20
Unicycive Therapeutics
Unicycive Therapeutics UNCY
Chief Financial Officer
Holding Value $553k 76,861 shares
Last Trade
Nov 21, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$263k 35,000 shares
$7.50
$7.20
Unicycive Therapeutics
Unicycive Therapeutics UNCY
Chief Financial Officer
Holding Value $301k 41,861 shares
Last Trade
Jul 15, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$696k 18,605 shares
$37.40
$7.20
Unicycive Therapeutics
Unicycive Therapeutics UNCY
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Jul 12, 2021 Sale
$1.16M 23,256 shares
$50.00
$7.20
Guardion Health Sciences
Guardion Health Sciences GHSI
Chief Accounting Officer
Holding Value $341k 105,000 shares
Last Trade
Aug 30, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$3.25
Guardion Health Sciences
Guardion Health Sciences GHSI
Holding Value $16.3k 5,000 shares
Last Trade
Dec 31, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$3.25
Guardion Health Sciences
Guardion Health Sciences GHSI
Holding Value $16.3k 5,000 shares
Last Trade
Dec 31, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$3.25
Plus Therapeutics
Plus Therapeutics PSTV
Controller
Holding Value $749k 138,205 shares
Last Trade
Jan 30, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$13.5B 10,000 shares
$1,350,000.00
$5.42
Plus Therapeutics
Plus Therapeutics PSTV
Controller
Holding Value $695k 128,205 shares
Last Trade
Aug 21, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$59.1B 15,000 shares
$3,937,500.00
$5.42
Plus Therapeutics
Plus Therapeutics PSTV
Controller
Holding Value $614k 113,205 shares
Last Trade
Apr 11, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$167B 25,000 shares
$6,693,750.00
$5.42
Plus Therapeutics
Plus Therapeutics PSTV
Controller
Holding Value $321k 59,205 shares
Last Trade
Jan 27, 2011 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$235B 15,000 shares
$15,665,625.00
$5.42
Plus Therapeutics
Plus Therapeutics PSTV
Controller
Holding Value $0 0 shares
Last Trade
Mar 05, 2010 Sale
$407B 20,000 shares
$20,334,375.00
$5.42
Plus Therapeutics
Plus Therapeutics PSTV
Controller
Holding Value $0 0 shares
Last Trade
Jun 07, 2009 Sale
$61.5B 5,000 shares
$12,290,625.00
$5.42
Plus Therapeutics
Plus Therapeutics PSTV
Controller
Holding Value $0 0 shares
Last Trade
Feb 02, 2009 Sale
$82.3B 6,500 shares
$12,656,250.00
$5.42
Plus Therapeutics
Plus Therapeutics PSTV
Controller
Holding Value $0 0 shares
Last Trade
May 02, 2007 Sale
$124B 7,438 shares
$16,621,875.00
$5.42
Plus Therapeutics
Plus Therapeutics PSTV
Controller
Holding Value $0 0 shares
Last Trade
Nov 24, 2005 Sale
$88.1B 3,600 shares
$24,468,750.00
$5.42

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up